PyInvesting

Market research

008930.KO Hanmi Science Co., Ltd

KO KRW Healthcare

Latest close

51,700.00 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
4T
P/E ratio
23.61
Analyst target
32381
Dividend yield
0.6%
Beta
0.51

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Hanmi Science Co., Ltd is currently in a long term uptrend where the price is trading 23.6% above its 200 day moving average.

From a valuation standpoint, the stock is 48.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.4.

Hanmi Science Co., Ltd's total revenue rose by 0.0% to $219B since the same quarter in the previous year.

Its net income has increased by 100.1% to $16B since the same quarter in the previous year.

Finally, its free cash flow grew by 252.3% to $4B since the same quarter in the previous year.

Based on the above factors, Hanmi Science Co., Ltd gets an overall score of 5/5.